Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

Share Price is delayed by 15 minutes
Get Live Data
97.02    -1.16 (-1.18%)
Bid:
96.98
Ask:
97.02
Spread: 0.04 (0.041%)
Market Cap: £56.51b
LLOY Live PriceLast checked at - London Stock Exchange

Intraday Lloyds Share Chart

Board Change

Today 11:09

RNS Number : 7766H
Lloyds Banking Group PLC
10 June 2026
 

10 June 2026

LLOYDS BANKING GROUP: BOARD APPOINTMENT

Lloyds Banking Group plc (the "Group") is pleased to announce the appointment of Danuta Gray as a Non-Executive Director of the Group and a member of its Responsible Business Committee and as Chair and a Non-Executive Director of Scottish Widows Group, in all cases with effect from 1 July 2026.

BIOGRAPHICAL DETAILS

Danuta is currently Chair of Croda International Plc and a Non-Executive Director and Chair of the Remuneration Committee at Burberry Group plc.

Danuta has significant financial services and insurance board experience, having chaired Direct Line Insurance Group plc from 2020 to 2025 and having served as a non-executive director of Aldermore Bank plc from 2014 to 2021, which included periods as Senior Independent Director and Interim Chair. Danuta has also been Chair and a Non-Executive Director of St Modwen Properties plc. 

Prior to her non-executive career, Danuta worked as an executive in the telecommunications sector where she held positions including Chief Executive Officer of Telefonica O2 Ireland and an Executive Board member of O2 plc.

Sir Robin Budenberg, Group Chair, said "Danuta is a very experienced non-executive director and chair who will bring extensive knowledge and experience of banking and insurance to her roles with the Group. She also has a track record of growing customer-focused and technology businesses. I look forward to welcoming her to the Group.".

There is no other information to be disclosed under UK Listing Rule 6.4.8R.

 

- END -

For further information:

Investor Relations

Douglas Radcliffe

Group Investor Relations Director

Email: douglas.radcliffe@lloydsbanking.com

 

Group Corporate Affairs

Matt Smith

Head of Media Relations

Email: matt.smith@lloydsbanking.com

 

+44 (0) 20 7356 1571

 

 

 

 

+44 (0) 7788 352 487

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAKKBKKBKDOAD
Date   Source Headline
10th Mar 20263:00 pmRNSDirector/PDMR Shareholding
9th Mar 20262:00 pmRNSDirector/PDMR Shareholding
9th Mar 20262:00 pmRNSDirector/PDMR Shareholding
9th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20266:04 pmRNSTransaction in Own Shares
5th Mar 20262:35 pmRNSDirector/PDMR Shareholding
4th Mar 20266:03 pmRNSTransaction in Own Shares
3rd Mar 20266:06 pmRNSTransaction in Own Shares
2nd Mar 20266:04 pmRNSTransaction in Own Shares
2nd Mar 20264:25 pmRNSIssue of Equity
27th Feb 20266:00 pmRNSTransaction in Own Shares
27th Feb 20264:18 pmRNSTotal Voting Rights
27th Feb 20262:49 pmRNSPublication of a Supplementary Prospectus
27th Feb 20261:32 pmRNSPublication of a Supplementary Prospectus
26th Feb 20265:57 pmRNSTransaction in Own Shares
26th Feb 20262:58 pmRNS2025 Form 20F Filed
26th Feb 202611:57 amRNS2025 Annual Report and Accounts
26th Feb 202611:57 amRNS2025 Annual Report and Accounts
26th Feb 202611:57 amRNS2025 Annual Report and Accounts
25th Feb 20266:19 pmRNSTransaction in Own Shares
25th Feb 20269:00 amRNS2025 Annual Report and Accounts
24th Feb 20266:03 pmRNSTransaction in Own Shares
23rd Feb 20265:50 pmRNSTransaction in Own Shares
20th Feb 20266:05 pmRNSTransaction in Own Shares
19th Feb 20266:08 pmRNSTransaction in Own Shares
18th Feb 20266:09 pmRNSTransaction in Own Shares
17th Feb 20265:56 pmRNSTransaction in Own Shares
16th Feb 20265:59 pmRNSTransaction in Own Shares
16th Feb 20261:02 pmRNSPublication of a Supplementary Prospectus
16th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20261:52 pmRNS2025 Form 20F Filed
13th Feb 202610:32 amRNS2025 Annual Report and Accounts
12th Feb 20265:51 pmRNSTransaction in Own Shares
11th Feb 20265:56 pmRNSTransaction in Own Shares
11th Feb 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20265:54 pmRNSTransaction in Own Shares
10th Feb 20262:14 pmRNSPublication of Final Terms
9th Feb 20266:16 pmRNSTransaction in Own Shares
6th Feb 20266:04 pmRNSTransaction in Own Shares
5th Feb 20266:01 pmRNSTransaction in Own Shares
5th Feb 20262:00 pmRNSDirector/PDMR Shareholding
4th Feb 20266:07 pmRNSTransaction in Own Shares
3rd Feb 20266:16 pmRNSTransaction in Own Shares
2nd Feb 20266:25 pmRNSTransaction in Own Shares
30th Jan 20266:20 pmRNSTransaction in Own Shares
30th Jan 20263:18 pmRNSTotal Voting Rights
30th Jan 202611:30 amRNSPublication of a Supplementary Prospectus
30th Jan 20267:02 amRNSCommencement of Share Buyback Programme
29th Jan 202612:00 pmRNSBoard Committee Change
29th Jan 20267:00 amRNS2025 results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.